investigator_user investigator user funding collaborators pending menu bell message arrow_up arrow_down filter layers globe marker add arrow close download edit facebook info linkedin minus plus save share search sort twitter remove user-plus user-minus
  • Project leads
  • Collaborators

Mechanism of Meiotic Recombination

Michael Lichten

2 Collaborator(s)

Funding source

National Cancer Institute (NIH)

Alastair Goldman

University of Sheffield

Sheffield, United Kingdom

Related projects

John Beulter

Biotechnology Engagement Program (BTEP) Supporting Scientific Redirection Through the Engagement of CIS Former Biological Weapons Scientists in Public Health Related Research Working in Collaboration with U.S. Scientists

All cancers but non-melanoma skin cancer

Leonard Neckers

Post-Translational Modifications of Hsp90 that Impact Drug Efficacy

All cancers but non-melanoma skin cancer

Levi A. Garraway

The Use of Whole-Exome Sequencing to Guide the Care of Cancer Patients

All cancers but non-melanoma skin cancer

Maria V Panchenko

Histone Acetyl Transferase HBO1 in kidney epithelial cell cycle

All cancers but non-melanoma skin cancer

Hiroaki Mitsuya

Study of HIV Protease Dimerization (PD) and Identification of PD Inhibitors 

All cancers but non-melanoma skin cancer

Richard L Haspel

A National Curriculum in Cancer Genomics for Pathology Residents

All cancers but non-melanoma skin cancer

Pathology

Xiaofeng Steven Zheng

Growth Control and Anti-Cancer Drug Mechanisms

All cancers but non-melanoma skin cancer

Renato V Iozzo

The Biology of Perlecan in Cancer and Angiogenesis

All cancers but non-melanoma skin cancer

Andrew H Beck

INFORMATICS METHODS AND MODELS FOR COMPUTATIONAL PATHOLOGY

All cancers but non-melanoma skin cancer